Suchen Sie nach Informationen zu Hauptsitz Von Jazz Pharmaceuticals? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.jazzpharma.com/about/global-footprint/united-states/
Jazz Pharmaceuticals U.S. Offices 3170 Porter Drive Palo Alto, CA 94304 Tel: 650 496 3777 5750 Fleet Street, Suite 200 Carlsbad, CA 92008 Tel: +1 760 795 2200 2005 Market Street Suite 2100 Philadelphia, PA 19103 Tel: 215 832 3750 For Medical Information Requests in the U.S. please click here. To Report an Adverse Event […]
https://www.jazzpharma.com/contact/
Jazz Pharmaceuticals Ireland Manufacturing & Development Monksland, Co. Roscommon, Ireland N37 AX84 Phone: +353-1 637 2022 or +353-1 634 7800. MADRID, SPAIN. Jazz Pharmaceuticals Iberia S.L. Calle Caleruega 102-104. Planta 7 Madrid 28033 Phone: + 34 91 949 1610. lyon, France. CityOne 84 quai Charles de Gaulle
https://www.jazzpharma.com/
The onset of cardiovascular events and risk factors is high among those living with narcolepsy, even among patients who do not have a history of these cardiovascular conditions. Learn more about the key findings of the CV-BOND study, recently presented by Rami H. Ben-Joseph, Ph.D., head of big data real world evidence at Jazz.
https://en.wikipedia.org/wiki/Jazz_Pharmaceuticals
https://www.dnb.com/business-directory/company-profiles.jazz_pharmaceuticals_inc.41288781a49b0cbeae93ec8a0659e627.html
Company Description: Jazz Pharmaceuticals, Inc. is located in Philadelphia, PA, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Jazz Pharmaceuticals, Inc. has 62 employees at this location. (Employees figure is modelled). There are 26 companies in the Jazz Pharmaceuticals, Inc. corporate family.
https://craft.co/jazz-pharmaceuticals
Jazz Pharmaceuticals is an international biopharmaceutical company, focused on identifying, developing, and commercializing products for neurology and psychiatry. The company's products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuria, an ...
http://investor.jazzpharma.com/investors
Investor Contacts. Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations. [email protected] Ireland: +353 1 634 7892 U.S.: +1 650 496 2800
https://www.forbes.com/companies/jazz-pharmaceuticals/
Jazz Pharmaceuticals (NASDAQ: JAZZ) is a biopharma company based in Ireland. Almost 75% of company’s revenues come from a single drug – Xyrum …
https://www.wallstreetoasis.com/company/jazz-pharmaceutical
Pharmaceutical Company Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients. We are focused on developing life-changing medicines for people with serious diseases-often with limited or no options-so they can live their lives more fully. By transforming biopharmaceutical …
https://www.bloomberg.com/profile/company/J2AZ34:BZ
Company profile page for Jazz Pharmaceuticals PLC including stock price, company news, press releases, executives, board members, and contact information
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Jazz Pharmaceuticals gefunden haben.
